Copernicus Capital Management’s Medtronic MDT Stock Holding History

Copernicus Capital Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$376K	Buy	+3,000	New	+$388K	4.55%	10

Other funds holding MDT

WestEnd Advisors Charlotte, North Carolina $4.49B AUM 19.44% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Copernicus Capital Management's MDT Position: Q3 2021 in Review

Copernicus Capital Management opened a new position in Medtronic (MDT) in Q3 2021: 3,000 shares worth $376K. The stake represents 4.55% of the portfolio and ranks #10 among its holdings.

2,023 funds tracked by Wall St. Rank hold MDT as of Q3 2021.

Copernicus Capital Management held 3,000 shares of Medtronic worth $376K as of Q3 2021.
Medtronic was a new Copernicus Capital Management position in Q3 2021.
Medtronic made up 4.55% of Copernicus Capital Management's portfolio in Q3 2021, its #10 holding.
2,023 funds tracked by Wall St. Rank held Medtronic as of Q3 2021.

Based on Copernicus Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.